Semaglutide and tirzepatide are two of the most talked-about medications in the current landscape of weight loss and type 2 diabetes research. With increasing media coverage and growing scientific interest, both have become central to the conversation about how to effectively treat metabolic disorders. While these medications may appear similar at first glance, they differ in how they work, the outcomes they produce, and how they’re used.